About the Conference

The 25th International Conference on Diabetes, Nutrition, Obesity, and Eating Disorders will take place on March 19-20, 2026, in Paris, France. This prestigious event will bring together leading researchers, healthcare professionals, nutritionists, endocrinologists, dialectologists, and industry experts to discuss the latest advancements and innovations in the fields of diabetes management, obesity prevention, nutritional science, and eating disorder treatment.

With the rising global burden of diabetes and obesity, this conference aims to foster knowledge exchange, promote collaboration, and explore cutting-edge research that can lead to improved healthcare strategies. Attendees will have the opportunity to engage in keynote presentations, panel discussions, workshops, and networking sessions. The event will also provide a platform for young researchers and students to present their findings through poster and oral presentations.

Key topics will include advances in diabetes treatment, metabolic disorders, nutritional therapies, behavioural approaches to obesity, and the psychological aspects of eating disorders. The conference will serve as a valuable opportunity for experts and professionals to share insights, establish new partnerships, and contribute to shaping the future of global health.

Target Audience

• Diabetes Educators
• Certified Diabetes Care Specialists
• Sports Medicine Specialists
• Exercise Physiologists
• Epidemiologists
• Public Health Researchers
• Healthcare Administrators
• Hospital Executives
• Alternative Medicine Practitioners
• Holistic Health Practitioners
• Behavioral Scientists
• Counselors
• Medical Device Developers
• Wearable Technology Developers
• Government Representatives in Healthcare
• NGO Representatives in Healthcare
• Healthcare Investors
• Venture Capitalists
• Media Professionals in Healthcare
• Science Communicators in Healthcare
• Patient Advocacy Groups
• Diabetes Support Organizations

Sessions and Tracks

Track-1:-Advances in Diabetes Treatment and Management

This track focuses on recent breakthroughs in diabetes management, including novel pharmacological treatments, non-insulin therapies, and continuous glucose monitoring systems. Experts will discuss personalized medicine approaches, combination therapies, and lifestyle modifications proven to enhance glycaemic control. The session will also highlight the latest research on SGLT2 inhibitors, GLP-1 receptor agonists, and next-generation insulin formulations. Additionally, topics such as diabetes remission strategies, behavioural interventions, and patient adherence to therapy will be explored. Attendees will leave with a comprehensive understanding of cutting-edge treatment methodologies, improving patient outcomes and quality of life.

Track-2:-Insulin Therapy and Medications

Insulin remains a cornerstone in diabetes management, but advancements in therapy have led to improved delivery systems and novel formulations. This session will delve into different insulin types, including ultra-rapid-acting, long-acting, and biosimilar insulins. Topics include insulin pumps, artificial pancreas technology, and alternative insulin administration methods such as oral and inhaled insulin. Experts will also discuss adjunctive therapies, emerging non-insulin medications, and combination treatment strategies. Understanding these advancements will help healthcare professionals optimize treatment regimens, reduce hypoglycaemia risks, and improve adherence among patients.

Track-3:-Diabetes Complications and Risk Factors

Diabetes is associated with several complications, ranging from cardiovascular diseases to neuropathy, nephropathy, and retinopathy. This session will focus on the pathogenesis of diabetes-related complications, risk assessment models, and early detection strategies. Experts will present the latest research on microvascular and macro vascular complications, their impact on overall health, and potential prevention methods. Discussion topics include chronic kidney disease, diabetic foot ulcers, cognitive impairment, and diabetes-related infections. The session will also cover lifestyle modifications, pharmacological interventions, and new treatment approaches to reduce complication risks.

Track-4:-Artificial Pancreas and Diabetes Technology

The integration of technology in diabetes care has revolutionized disease management. This session will highlight advancements in artificial pancreas systems, continuous glucose monitoring (CGM), and insulin pump innovations. Experts will discuss the role of artificial intelligence (AI) and machine learning in predicting glucose fluctuations and automating insulin delivery. Other topics include mobile health applications, smart insulin pens, and remote patient monitoring. Attendees will explore the latest research on closed-loop insulin delivery systems and wearable medical devices, offering new perspectives on improving glycemic control and enhancing patient autonomy.

Track-5:-Diabetes and Cardiovascular Diseases

Cardiovascular diseases (CVD) remain a leading cause of morbidity and mortality in diabetic patients. This session examines the relationship between diabetes and CVD, covering atherosclerosis, heart failure, and hypertension in diabetic individuals. Experts will present data on cardiovascular outcome trials (CVOTs) assessing the impact of diabetes medications on heart health. Topics include lipid management, inflammation’s role in cardiovascular risk, and lifestyle interventions. The session will also explore innovative therapeutic approaches, including GLP-1 receptor agonists and SGLT2 inhibitors, which have shown cardiovascular benefits.

Track-6:-Gestational Diabetes and Pregnancy Complications

Gestational diabetes mellitus (GDM) affects both maternal and fetal health, increasing the risk of pregnancy complications and long-term metabolic disorders. This session will cover risk factors, screening methods, and diagnostic criteria for GDM. Experts will discuss the impact of maternal hyperglycemia on fetal development and long-term health outcomes for both mother and child. Management strategies, including dietary interventions, pharmacotherapy, and postpartum follow-up care, will be explored. The session will also address the importance of early detection and lifestyle interventions in preventing Type 2 diabetes development in women with a history of GDM.

Track-7:-Nutritional Approaches for Diabetes Management

Diet plays a crucial role in diabetes management, influencing blood sugar levels, insulin sensitivity, and overall metabolic health. This session will discuss evidence-based dietary approaches, including low-carbohydrate diets, the Mediterranean diet, and plant-based nutrition. Experts will explore the role of macronutrient composition, fiber intake, and meal timing in glycemic control. Emerging trends in diabetes nutrition, such as intermittent fasting and ketogenic diets, will also be analyzed. Attendees will gain insights into practical dietary strategies that healthcare professionals can implement to help patients optimize their metabolic health and prevent diabetes-related complications.

Track-8:-Personalized Nutrition and Meal Planning

Personalized nutrition is a growing field that tailors dietary recommendations based on an individual’s genetics, gut microbiome, and metabolic responses. This session will explore the latest research in precision nutrition for diabetes, obesity, and metabolic disorders. Topics include nutrigenomics, metabolic phenotyping, and AI-driven diet plans. Experts will discuss how advancements in wearable technology and continuous glucose monitoring are revolutionizing personalized dietary interventions. Case studies on meal planning for different populations, including athletes, pregnant women, and elderly patients with diabetes, will be presented.

Track-9:-Role of Functional Foods and Supplements

Functional foods, such as probiotics, prebiotics, and bioactive compounds, offer promising health benefits in managing diabetes, obesity, and metabolic disorders. This session will examine the role of dietary supplements, herbal extracts, and superfoods in improving insulin sensitivity and reducing inflammation. Topics will include the impact of omega-3 fatty acids, polyphenols, and dietary fibers on metabolic health. Experts will discuss the scientific evidence supporting these functional foods and their integration into clinical nutrition guidelines. Attendees will gain practical insights into incorporating evidence-based functional foods into patient care.

Track-10:-Plant-Based Diets and Metabolic Health

Plant-based diets have been increasingly recognized for their role in preventing and managing metabolic diseases. This session will explore how vegetarian, vegan, and flexitarian diets impact insulin resistance, obesity, and cardiovascular health. Experts will discuss nutrient adequacy, protein sources, and essential micronutrient considerations for individuals following plant-based eating patterns. Case studies highlighting the long-term effects of plant-based diets on Type 2 diabetes and obesity management will be presented. The session will also provide practical guidance on meal planning and transitioning patients toward plant-based eating.

Track-11:-Nutrigenomics and Personalized Diet Plans

Nutrigenomics is an emerging field that studies how genes interact with dietary components to influence health outcomes. This session will explore how genetic variations affect nutrient metabolism, obesity susceptibility, and insulin sensitivity. Experts will discuss how genomic testing can be used to develop personalized diet plans for individuals with diabetes, obesity, or metabolic syndrome. The session will cover key genes involved in nutrient absorption, lipid metabolism, and inflammatory responses. Attendees will learn about the clinical applications of nutrigenomics in dietary counseling and how to integrate genetic insights into patient care.

Track-12:-Gut Microbiome and Metabolic Disorders

The gut microbiome plays a significant role in metabolic health, influencing insulin resistance, inflammation, and obesity. This session will delve into the relationship between gut bacteria and metabolic diseases, highlighting the latest research on probiotics, prebiotics, and fecal microbiota transplantation (FMT). Experts will discuss how dietary modifications can enhance gut microbial diversity and improve metabolic outcomes. Topics include the role of short-chain fatty acids, dysbiosis in diabetes, and microbiome-targeted therapies. Attendees will gain insights into practical applications for restoring gut health through diet, probiotics, and lifestyle interventions.

Track-13:-Clinical Nutrition and Malnutrition

Proper nutrition is essential for managing chronic diseases, yet malnutrition remains a major concern in diabetic and obese populations. This session will explore the impact of undernutrition and overnutrition on metabolic health. Experts will discuss strategies for addressing protein-energy malnutrition, sarcopenic obesity, and micronutrient deficiencies in at-risk populations. Topics include hospital-based nutrition interventions, enteral and parenteral nutrition for diabetic patients, and screening tools for nutritional assessment. Case studies on integrating medical nutrition therapy into clinical practice will be presented.

Track-14:-Causes and Consequences of Obesity

Obesity is a complex condition influenced by genetic, environmental, and behavioral factors. This session will explore the underlying causes of obesity, including metabolic adaptations, hormonal imbalances, and lifestyle habits. Experts will discuss the long-term health consequences of obesity, such as Type 2 diabetes, cardiovascular diseases, and fatty liver disease. The session will also examine the latest research on the obesity paradox and its implications for treatment.

Track-15:-Behavioral and Psychological Aspects of Obesity

Psychological factors play a crucial role in obesity development and management. This session will discuss the impact of emotional eating, stress, depression, and sleep disorders on weight gain. Experts will explore behavioral interventions, including cognitive-behavioral therapy (CBT), mindfulness-based approaches, and habit modification strategies. Attendees will gain insights into patient-centered approaches that address the emotional and psychological aspects of obesity.

Track-16:-Anti-Obesity Medications and Therapies

Pharmacological treatments for obesity have evolved significantly in recent years. This session will highlight FDA-approved anti-obesity drugs, their mechanisms of action, and their effectiveness in weight management. Experts will discuss emerging medications such as GLP-1 receptor agonists and combination drug therapies. The session will also explore the role of personalized medicine in obesity pharmacotherapy and potential future treatments.

Track-17:-Surgical Interventions for Weight Loss

Bariatric surgery is a highly effective intervention for severe obesity and metabolic disorders. This session will cover different surgical procedures, including gastric bypass, sleeve gastrectomy, and duodenal switch. Experts will discuss surgical outcomes, patient selection criteria, and post-operative nutritional management. Case studies on long-term weight loss success and metabolic improvements after bariatric surgery will be presented.

Track-18:-Obesity in Children and Adolescents

Childhood obesity is a growing public health crisis with long-term health implications. This session will focus on the risk factors, early interventions, and prevention strategies for pediatric obesity. Experts will discuss the role of school-based programs, parental involvement, and policy changes in reducing childhood obesity rates. Topics will also include the psychological and social impacts of obesity in children.

Track-19:-Anorexia Nervosa, Bulimia, and Binge Eating Disorders

Eating disorders such as anorexia nervosa, bulimia nervosa, and binge eating disorder (BED) significantly impact physical and mental health. This session explores the etiology, risk factors, and neurological mechanisms underlying these disorders. Experts will discuss diagnostic challenges, medical complications, and psychological interventions, including cognitive-behavioral therapy (CBT) and dialectical behavior therapy (DBT). The session will also highlight the role of genetics, gut microbiota, and metabolic disruptions in eating disorders. Strategies for early detection, prevention, and multidisciplinary treatment approaches will be covered to improve long-term patient outcomes.

Track-20:-Psychological and Behavioral Therapies

Mental health plays a crucial role in the development and treatment of eating disorders. This session will focus on evidence-based psychological interventions, including CBT, DBT, and acceptance and commitment therapy (ACT). Experts will discuss emerging therapeutic approaches such as virtual reality exposure therapy and digital cognitive interventions. Topics include behavior modification techniques, emotional regulation, and the role of self-compassion in recovery. Attendees will gain insights into how mental health professionals can collaborate with dietitians and physicians to provide holistic care for individuals struggling with disordered eating patterns.

Benefits of Participation

• Global networking with experts & professionals
• Showcase research & gain recognition
• Publication in conference proceedings & journals
• Access to keynotes, panels & workshops
• Latest updates on diabetes, nutrition & obesity
• Career growth & collaboration opportunities
• Awards & recognition for outstanding research
• Interactive discussions & Q&A sessions
• Sponsorship & funding opportunities
• CME & CPD accreditation for professionals
• Industry exposure for exhibitors & startups
• Exclusive sessions for young researchers & students
• Hands-on learning with case studies & innovations
• Business & branding opportunities for companies
• Contribution to global healthcare advancements
• Present research & gain global visibility
• Network with top experts & professionals
• Publish abstracts in indexed journals
• Learn latest advancements & innovations
• Exclusive awards for researchers & students
• Career-building opportunities & collaborations

Awards & Opportunities

• Diabesity 2026 acknowledges participants for outstanding contributions to the field.

  Awards Presented:

• Young Scientist Award
• Best Speaker Award
• Best Poster Award
• Best Keynote Speaker Award
• Best Organizing Committee Member Award

  Selection Criteria:

• Overall abstract quality
• Timeliness of the topic
• Relevance to the conference scope and mission
• Well-defined focus within the program track structure
• Join us Diabesity 2026 by submitting your Abstract

Market Analysis

The global market for diabetes, nutrition, obesity, and eating disorders is witnessing rapid growth due to the increasing prevalence of metabolic disorders, rising healthcare investments, and advancements in treatment approaches. The diabetes care market is expanding with innovations in insulin delivery systems and continuous glucose monitoring devices. The obesity management market is driven by lifestyle changes, weight-loss medications, and surgical interventions. The nutrition sector is booming due to the rising demand for functional foods and dietary supplements. Meanwhile, awareness and mental health initiatives are fueling the eating disorders treatment market, encouraging digital and psychological intervention programs.

Market Challenges

• High Treatment Costs: Advanced therapies, continuous monitoring devices, and medications remain expensive, limiting access to care.
• Regulatory Barriers: Stringent regulations for drug approvals, medical devices, and nutritional products slow market growth.
• Lack of Awareness: In developing regions, limited awareness about obesity, diabetes prevention, and eating disorders affects early diagnosis and treatment.
• Technological Gaps: While digital health is growing, many healthcare systems still lack access to AI-driven solutions and remote monitoring tools.
• Psychological Stigma: Eating disorders and obesity often carry social stigma, discouraging individuals from seeking treatment.

Conclusion

The market for diabetes, nutrition, obesity, and eating disorders presents significant opportunities, driven by technological advancements, increasing healthcare expenditure, and public health awareness. Despite challenges like high costs, regulatory constraints, and limited accessibility, the growing adoption of digital health solutions, personalized medicine, and lifestyle interventions is expected to shape the future of this sector. Collaboration between researchers, healthcare professionals, and industry leaders will be crucial in addressing these challenges and driving innovation for better patient outcomes.